Background: Sexually transmitted infections (STIs) are a significant public health concern worldwide, yet data on their prevalence and epidemiology, particularly in Central and Eastern Europe, remain scarce. This study aimed to assess the prevalence, anatomical localization, symptomatic/asymptomatic course, and co-infection patterns of STIs among men. Methods: This retrospective study analyzed data collected between May 2021 and July 2023, including sociodemographic, sexual behavior, and clinical data from 139 male participants. Molecular polymerase chain reaction (PCR) tests were conducted for Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Mycoplasma genitalium, and Trichomonas vaginalis. Results: Of the participants, 36% tested positive for at least one STI, with the urethra being the most common site of infection. NG and CT were the most prevalent infections. The majority of infections were asymptomatic, highlighting the importance of comprehensive screening, especially in high-risk populations like men who have sex with men (MSM). Conclusions: This study emphasizes the need for targeted screening strategies, particularly for extragenital STIs, and underscores the role of MSM in STI epidemiology. The findings highlight the importance of routine screening, even for asymptomatic individuals, to effectively control STI spread. Future research should validate and expand upon these findings to enhance STI prevention and management efforts.
Pemphigus is a rare autoimmune bullous disease, with pemphigus vulgaris (PV) and pemphigus foliaceous (PF) being its most common forms. This report presents a case of PF triggered by vaccinations. A previously healthy 38-year-old Caucasian man developed skin lesions six months after receiving vaccinations for hepatitis A, rabies, cholera, typhoid fever, and yellow fever before travelling to Sudan. Examination revealed pruritic erosions, crusts, and flaccid blisters primarily on the trunk and limbs. Histopathology was nonspecific, but direct immunofluorescence showed intercellular IgG, C3c, and C1q deposits. Elevated autoantibodies against desmoglein 1 (DSG1) confirmed the PF diagnosis. The patient responded well to oral prednisone and topical treatments, with complete resolution of symptoms within six months. The aetiology of pemphigus remains unclear, but vaccines can nonspecifically activate the immune system, potentially triggering pemphigus in predisposed individuals. This case highlights the need to consider pemphigus as a potential adverse effect of vaccination. Keywords: pemphigus foliaceous vaccinations
Expression of concern BACKGROUND: While bacterial sexually transmitted infections (STIs) have increased across Europe over the past decade, Poland continuously reported the lowest notification rates in the European Union/European Economic Area (EU/EEA), raising concerns about under-ascertainment and diagnostic gaps. AIM: We describe national STI trends in Poland from 2013 to 2024, temporal changes around 2020 and subsequent years, and demographic and geographic patterns relevant for STI control. METHODS: We analysed aggregated statutory surveillance data for syphilis, gonorrhoea and C hlamydia trachomatis infections, and calculated annual incidence rates overall and by sex, age group and voivodeship. Temporal trends were assessed using year-over-year per cent change and average annual per cent change (AAPC) estimated from log-linear models. RESULTS: All three infections increased modestly before 2020, declined in 2020 and increased markedly thereafter. Between 2013 and 2024, incidence increased 2.7–3.8-fold. It was highest among men, young adults aged 20–34 years and in urbanised regions. By 2023, syphilis incidence reached 7.92 per 100,000 population in Poland compared with 9.9 per 100,000 in the EU/EEA, whereas gonorrhoea and chlamydia incidence remained substantially lower. National AAPC estimates were not statistically significant, although they increased in several demographic groups and voivodeships. CONCLUSION: Reported bacterial STI notifications in Poland are increasing, particularly among young adults and in urban regions. Persistently low gonorrhoea and chlamydia notification rates relative to EU/EEA levels probably reflect differences in diagnostic access and testing intensity rather than low transmission. Improving surveillance completeness, access to NAAT diagnostics, and testing coverage will be important to enhance detection and control.
Introduction: Bullous pemphigoid is an autoimmune bullous disease, affecting elderly people, most often in the 8th decade of life. The article aims to present a rare case of bullous pemphigoid manifested at an atypically young age, occurred with long-standing psoriasis and was successfully treated with methotrexate. Case report: A 40-year-old male presented to the department with the presence of bullous lesions on the limbs and trunk, together with psoriatic papules and plaques in the lumbar region and lower limbs, stating the history of psoriasis. Based on clinical, direct immunofluorescence and serological findings, bullous pemphigoid was diagnosed. For the treatment methotrexate and topical clobetasol propionate cream were used with a good clinical response after 4 weeks. Discussion: The coexistence of psoriasis and bullous pemphigoid is not common and poses a therapeutic challenge. Methotrexate can be a good treatment option for these patients. Future research is needed to explain the pathogenic mechanism of bullous pemphigoid and psoriasis coexistence. Introduction: Bullous pemphigoid is an autoimmune bullous disease, affecting elderly people, most often in the 8th decade of life. The article aims to present a rare case of bullous pemphigoid manifested at an atypically young age, occurred with long-standing psoriasis and was successfully treated with methotrexate. Case report: A 40-year-old male presented to the department with the presence of bullous lesions on the limbs and trunk, together with psoriatic papules and plaques in the lumbar region and lower limbs, stating the history of psoriasis. Based on clinical, direct immunofluorescence and serological findings, bullous pemphigoid was diagnosed. For the treatment methotrexate and topical clobetasol propionate cream were used with a good clinical response after 4 weeks. Discussion: The coexistence of psoriasis and bullous pemphigoid is not common and poses a therapeutic challenge. Methotrexate can be a good treatment option for these patients. Future research is needed to explain the pathogenic mechanism of bullous pemphigoid and psoriasis coexistence.
Background: Lymphogranuloma venereum (LGV) caused by Chlamydia trachomatis serovars L1–L3 is increasingly reported among men who have sex with men (MSM) in Western Europe, yet appears to remain underrecognised in Central and Eastern Europe. We describe clinical characteristics, diagnostic pathways, and outcomes of LGV cases in Poland to highlight recognition barriers and public health implications. Methods: We conducted a retrospective case series of symptomatic MSM diagnosed with LGV at a dermatovenereology outpatient clinic in Gdańsk, Poland, between 1 December 2023 and 31 October 2025. Cases were confirmed by C. trachomatis nucleic acid amplification test followed by LGV-discriminatory PCR. We extracted demographic, clinical, laboratory, and treatment data from electronic records. Results: Seven MSM (median age 28 years, range 25–68) were diagnosed with LGV; five (71%) were living with HIV. Common symptoms included rectal bleeding, rectal pain, and mucopurulent discharge (each 71%). Median time from symptom onset to diagnosis was 6 months (range 2 weeks–7 months); patients consulted a median of 3 physicians (range 1–5) before diagnosis. Five underwent colonoscopy with findings initially suggesting inflammatory bowel disease or malignancy. Concurrent sexually transmitted infections were frequent, including gonorrhoea (57%), syphilis (29%), and herpes simplex virus (29%). All received doxycycline 100 mg twice daily for 21 days. Three patients—all with diagnostic delays ≥ 6 months—reported persistent anorectal symptoms post-treatment despite microbiological cure. Conclusions: LGV may be underdiagnosed in Poland, and diagnostic delays exceeding six months may be associated with persistent symptoms despite microbiological cure. Enhanced clinician awareness, routine sexual history-taking in both primary and specialist care, and improved access to LGV-discriminatory testing are needed to reduce morbidity and prevent irreversible complications in this vulnerable population.